Livzon pharmaceutical secures Rmb 1.27bn in guarantees for key subsidiaries

In September 2025, Livzon Pharmaceutical Group Co., Ltd. finalized guarantee agreements with Standard Chartered Bank (China) Limited, Zhuhai Branch. These agreements provide maximum guarantee liability for a total of RMB 1,267,250,000 across multiple subsidiaries, including Gutian Fuxing Pharmaceutical Co., Ltd., Jiaozuo Livzon Pharmaceutical Co., Ltd., Livzon Group (Ningxia) Pharmaceutical Co., Ltd., Livzon Group Fuzhou Fuxing Pharmaceutical Co., Ltd., Livzon Group Livzon Pharmaceutical Factory, Livzon Group Xinbeiji Pharmaceutical Co., Ltd., Sichuan Guangda Pharmaceutical Co., Ltd., Zhuhai Free Trade Zone Livzon Pharmaceutical Co., Ltd., and Zhuhai Livzon Pharmaceutical Trading Co., Ltd. The guarantees cover the principal debt and extend for three years beyond the maturity of the underlying debt.

As of September 30, 2025, Livzon Pharmaceutical's outstanding guarantee balance for its controlled subsidiaries reached RMB 217,183,930. This represents 15.67% of the company's net assets attributable to shareholders, which were RMB 1,386,233,420 in the latest audited period. Of this amount, RMB 135,600,600 is for subsidiaries with an asset-liability ratio above 70%, and RMB 81,583,320 for those below 70%.

The company confirmed that there are no external guarantees beyond those for wholly-owned or controlled subsidiaries, and no overdue guarantees or guarantees involved in litigation that could result in losses.